BOLTON SECURITIES CORPORATION’s Avanos Medical AVNS Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$860	Buy	+60	New	+$937	﹤0.01%	1791

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Paradice Investment Management Denver, Colorado $594M AUM 28.38% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's AVNS Position: Q1 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in Avanos Medical (AVNS) in Q1 2025: 60 shares worth $860. The stake represents ﹤0.01% of the portfolio and ranks #1791 among its holdings.

281 funds tracked by Wall St. Rank hold AVNS as of Q1 2025.

BOLTON SECURITIES CORPORATION held 60 shares of Avanos Medical worth $860 as of Q1 2025.
Avanos Medical was a new BOLTON SECURITIES CORPORATION position in Q1 2025.
Avanos Medical made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2025, its #1791 holding.
281 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2025, filed 12 Nov 2026.